{"name":"Bird Rock Bio, Inc.","slug":"bird-rock-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Gerilimzumab","genericName":"Gerilimzumab","slug":"gerilimzumab","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Gerilimzumab","genericName":"Gerilimzumab","slug":"gerilimzumab","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5kZ1pILXhqMC00Mm96LXV1U0FIS20xeE1IaVpSckFnSndCUGJIMVhxLUp0Tk92MEFwUnVBMktmS0lFODJnM2I5X2dYN0ZaY1dvNGF4b0ZtZHhlWk1w?oc=5","date":"2026-02-25","type":"pipeline","source":"EurekAlert!","summary":"New blood test score detects hidden alcohol-related liver disease - EurekAlert!","headline":"New blood test score detects hidden alcohol-related liver disease - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-27","type":"pipeline","source":"GlobeNewswire","summary":"Gastroparesis Market Poised for Extraordinary Growth at a - GlobeNewswire","headline":"Gastroparesis Market Poised for Extraordinary Growth at a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQcjhBT0MwS3FTbjd3WDk0eTB6cHJWSUJPNjhibjFqVFZTMzdMVWxrdDAxV3VrSE1ncjhBbDlwWUpYeWlvcV80M3JFYy1LdUUzeUtBLWJXWDJqc0g5aUdOUENIQmwyQzUtSWZkOFY3ellPRWxLOFVtWTRjVm5TYUc4ZEF1Tlh1QU9YNFZieWN1cWh2U2Z0ZnI0QWFHcXg4SUo1aFNsYTBiX0ljUQ?oc=5","date":"2025-10-06","type":"trial","source":"BioWorld News","summary":"Skye hopeful on next steps for obesity drug despite phase II miss - BioWorld News","headline":"Skye hopeful on next steps for obesity drug despite phase II miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNLWtqS08wUlg5M3lFQ0Nia2E0UnVKYlhfdXBBdnRGNEJDMk9BUGhMYzVEQktkOHdnTmhTQ3V1TmN2bzdid3BYd29qS29qN3BGNVVtMklzYmE0RXRpR1Y4Q3Y5VVZqWWFFcDRKRldSN0IzSGsweHIyaTNQRjlGNUVKX3ZvamE5bk9YT09kaGdvQWhtNlByOXlKR0drNUM1Z0wwd25B?oc=5","date":"2024-06-10","type":"trial","source":"MedCity News","summary":"Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program - MedCity News","headline":"Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxONVc3QVk5SFRFWjhMNUl3c1g1Y3RGZHJEd3ppZzhSOWpZNkxLbzFsQ2ZTaEQ1VU9VSEpmcHY0Tm9jSDFZbnJHX0RPdTJEdllDXzh2MWI5NE5IUGctNTR0ai0zbjFzUmp5b3RRRkd5cTZGUHoyNWNwMTNNY05NZFREQUhEdEg4LTFmOTFweTRjVVdUNUFVaUE0dHowbm55NWxrdXUtQ3NSUFJaaGhuaHNiVTVDZGtzWmNRa3gwcjlkWlE1RE1nLXJuZnFLVFVBdlBQcEhoMVJrUFJzdw?oc=5","date":"2024-04-10","type":"pipeline","source":"PR Newswire","summary":"Gastroparesis Market to Witness Upsurge in Growth at a CAGR of 7% by 2034 | DelveInsight - PR Newswire","headline":"Gastroparesis Market to Witness Upsurge in Growth at a CAGR of 7% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNV2k4Z01FMUNUME9kc0JERmFUQUMzZDdMVkZTcDl5WkpWNW1qSlZpYVZQQkZvcllWWk96bVB4dzB6Q2FaTjRGaVh1dzF6Q09ZaXU4bHJTT3Q5aXk5ZWY1dXlQZHJJZnBSN2ctVVpGY3lBb3dQbkVtLWh5TW5pTDdEVGxBU282S3lsV3gtR3FGdnNuTEFGZ0Fxek9PdVB2NlJQQkppM1kwMjdFVWNJcEdzZVJB?oc=5","date":"2023-10-06","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Lilly's US leader takes charge of key diabetes and obesity unit - Fierce Biotech","headline":"Chutes & Ladders—Lilly's US leader takes charge of key diabetes and obesity unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVHBzWmR0d1IwZjk2UmlVcnYtMmhhcllkRmdlemZOQlFZZXJ6dEJ3cmFZZ1IxdDZHakI5QTNNR0R3SXcwWkYzVXBOcDlMZGd4cF9aQ3VGc3A2UDZoTFEtQk9sWG5yNTZNMXgyV3FvWkdUVkJKRHhJX3JjZlF2b2ZBODZXUU85dW43?oc=5","date":"2020-05-14","type":"pipeline","source":"Yahoo","summary":"What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain - Yahoo","headline":"What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1NUXdGcnRRSEdrSGZfQ1FGc1lrSkJobFdsUnFnT2VRZ2xKb3laYUh5Z25yZmNiUlFCck9HUkw0UHU0LUFOTWI0cGpMOHYyTEpnelVDN3JRdTMyaGsxN3JlZ2l2UGUzMWk1cWFuSWxKQ1ZOYk95Y1lJ?oc=5","date":"2017-01-12","type":"pipeline","source":"BioPharma Dive","summary":"Bird Rock one step closer to acquisition by J&J - BioPharma Dive","headline":"Bird Rock one step closer to acquisition by J&J","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQX2FXTVBuWjlyU29HbGRZS0g1WEI4UEVmWmNkUVg1a3AwSjk5clZvcEdCbl83OVBQZ2k1a2lTWVJ1dldiRUdmSk9JeUphaHlqRS0ydGNhM1VVTzFaSS1waDlLM28wQkgyaVA3b0VyYUl5NFh3azBzODM5Y2F1SmJlbEhibDVVeXJURnBTbk4tcm1UTl9OODRZWkdvc0U5UXRTWUIzX2JtblpEdzU4SGZFRkZlZzQ2RDI2ZGI5RV9CSnZ6RjBxdnZUNjV1WDZxVlpWa25fWGlaQjUtZ2dkYkNJVHVjcm5NUVNudmhhbzg3X3VrWUFLdVVMTmwxcWwzU1FRaFhGd1pBVQ?oc=5","date":"2017-01-05","type":"deal","source":"PR Newswire","summary":"Johnson & Johnson Innovation's Global Pursuit of Cutting-Edge Science Yields 15 New Collaborations, Pushing Total Above 300 - PR Newswire","headline":"Johnson & Johnson Innovation's Global Pursuit of Cutting-Edge Science Yields 15 New Collaborations, Pushing Total Above ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}